You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

individualized immunotherapy

Showing 1 - 25 of 5,346
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Individualized Immunotherapy Strategy and Platform Based on

Recruiting
  • Gut Microbiota
    • Xi'an, China
      Jianjun Yang
    Nov 11, 2022

    Classical Hodgkin Lymphoma Trial in Cologne (Tislelizumab)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Aug 5, 2022

    I3LUNG: Integrative Science, Intelligent Data Platform for

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
      • Chicago, Illinois
      • +3 more
      Sep 13, 2022

      Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)

      Not yet recruiting
      • Stage III Non-small Cell Lung Cancer
      • Adaptive Radiotherapy
      • +3 more
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 3, 2022

      Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)

      Not yet recruiting
      • Colon Cancer
      • Immunotherapy
      • Chongqing, China
        Daping hospital
      Apr 16, 2023

      Breast Cancer Trial in United States (radiation, drug, biological)

      Recruiting
      • Breast Cancer
      • Focal Radiation therapy
      • +2 more
      • Los Angeles, California
      • +6 more
      Apr 29, 2022

      The Tumor Microenvironment for Locally Advanced Resectable

      Recruiting
      • Gastric Adenocarcinoma
      • Gastroesophageal Junction Adenocarcinoma
      • non-intervention
      • Guangzhou, Guangdong, China
        Nanfang Hospital, Southern Medical University
      Mar 24, 2022

      Immunotherapy, Gastric Cancer, Rectal Cancer Trial (Terelizumab, CapeOx, Trastuzumab)

      Not yet recruiting
      • Immunotherapy
      • +4 more
      • (no location specified)
      Aug 24, 2022

      Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)

      Recruiting
      • Lung Cancer
      • Jinan, Shandong, China
        The First Affiliated Hospital of Shandong First Medical Universi
      Dec 7, 2022

      Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

      Not yet recruiting
      • Adrenal Cortical Carcinoma
      • +3 more
      • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
      Nov 19, 2023

      Microenvironment of Lung Cancer and Exploration of Mechanism of

      Recruiting
      • Lung Cancer
      • Multiomics analysis
      • Yiwu, Zhejiang, China
        The Fourth Affiliated Hospital of Zhejiang University
      Dec 16, 2022

      Colonic Tumors, Colorectal Tumors Trial in Detroit, New York, Cincinnati (GRT-C901, GRT-R902, Atezolizumab)

      Recruiting
      • Colonic Neoplasms
      • Colorectal Neoplasms
      • Detroit, Michigan
      • +2 more
      Aug 1, 2022

      Breast Cancer, Colo-rectal Cancer, Lung Cancer Trial in Bobigny (Physical activity program)

      Recruiting
      • Breast Cancer
      • +3 more
      • Physical activity program
      • Bobigny, France
        Laboratoire Educations et Promotion de la Santé UR3412
      May 18, 2022

      Metastatic Renal Cell Cancer Trial in United States (Axitinib)

      Active, not recruiting
      Has Results
      • Metastatic Renal Cell Cancer
      • Duarte, California
      • +3 more
      Jun 1, 2022

      NSCLC Trial in Tübingen, Münich, Heidelberg (Photons)

      Recruiting
      • Non-small Cell Lung Cancer
      • Photons
      • Tübingen, Baden-Württemberg, Germany
      • +2 more
      Aug 19, 2022

      Treatment Efficacy Trial in Baltimore (Peanut Flour)

      Completed
      Has Results
      • Treatment Efficacy
      • Peanut Flour
      • Baltimore, Maryland
        Johns Hopkins
      Oct 27, 2021

      APOLLO 11, Consortium of Italian Centers Involved in Treatment

      Not yet recruiting
      • NSCLC
      • +4 more
        • (no location specified)
        Sep 19, 2022

        Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

        Recruiting
        • Pancreatic Adenocarcinoma Metastatic
        • Nanjing, Jiangsu, China
          The Affiliated Nanjing Drum Tower Hospital of Nanjing University
        Sep 18, 2023

        Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

        Not yet recruiting
        • Endometrial Carcinoma
        • Tumor Molecular Features Screening Model
        • open surgery
        • laparoscopic surgery
        • (no location specified)
        Jun 7, 2023

        Symptoms Based on Patient-reported Outcomes in Immunotherapy for

        Not yet recruiting
        • Esophageal Cancer
        • +2 more
          • Guangzhou, Guangdong, China
            Guangdong Provincial People's Hospital
          Aug 24, 2023

          Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H

          Recruiting
          • Colorectal Cancer
            • Shanghai, China
              Fudan University Shanghai Cancer Center
            Oct 18, 2023

            Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Atlanta, Decatur (Educational video, Interview,

            Recruiting
            • Hematopoietic and Lymphoid System Neoplasm
            • Malignant Solid Neoplasm
            • Educational video
            • +2 more
            • Atlanta, Georgia
            • +1 more
            May 16, 2023

            Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

            Recruiting
            • Lung Cancer
              • Shanghai, China
                Shanghai Chest Hospital
              Jul 20, 2023

              Lung Cancer Trial in Reggio Emilia (Pulmonary rehabilitation)

              Recruiting
              • Lung Cancer
              • Pulmonary rehabilitation
              • Reggio Emilia, Italy
                Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia
              Sep 17, 2023

              Minimally Residual of Esophageal Cancer 001

              Recruiting
              • Esophageal Carcinoma
              • Minimal Residual Disease
                • Shijiazhuang, Hebei, China
                  Fourth Hospital of Hebei Medical University
                Jul 17, 2023